Albemarle (ALB) Cash & Equivalents (2009 - 2026)

Albemarle (ALB) has 18 years of Cash & Equivalents data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 28.23% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 28.23% YoY), and the FY2025 full-year result was $1.6 billion, up 35.71% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $1.1 billion, down from $1.6 billion in the prior quarter.
• Across five years, Cash & Equivalents topped out at $2.1 billion in Q1 2024 and bottomed at $463.3 million in Q1 2022.
• The 5-year median for Cash & Equivalents is $1.6 billion (2023), against an average of $1.5 billion.
• Peak annual rise in Cash & Equivalents reached 242.47% in 2023, while the deepest fall reached 40.64% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $1.5 billion in 2022, then slumped by 40.64% to $889.9 million in 2023, then jumped by 33.97% to $1.2 billion in 2024, then soared by 35.71% to $1.6 billion in 2025, then sank by 32.64% to $1.1 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.1 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.

Peer Comparison